In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Helix Opco LLC

www.helix.com

Latest From Helix Opco LLC

Device/Diagnostics Quarterly Deal Statistics, Q2 2016

Medtech companies brought in $1.5 billion in Q2 2016, 15% less than Q1, with debt offerings accounting for more than half the total; acquisitions more than doubled due to Abbott's $25 billion takeover of St. Jude Medical. Diagnostics financings were down 34% from Q1 and acquisition volume, also lower, was mainly Thermo Fisher Scientific's $4.2 billion buy of FEI.

Deals Market Intelligence

The A-List: The Trend-Shaping Series A Financings Of 2015

Our 12th annual analysis reveals both an expansion of historical patterns of Series A financings and the emergence of a new group of heavily committed, relatively short-term investors.

BioPharmaceutical Medical Device

Device/Diagnostics Quarterly Deal Statistics, Q3 2015

$1.4 billion in Q3 device financing was slightly lower than Q2's $1.8 billion with just one IPO versus Q2's seven. Acquisitions reached a high of $23 billion and diagnostics financing increased 30% over Q2 to $1 billion, while M&A activity at $1.2 billion showed a sharp decline from the previous quarter's $15.6 billion.

Medical Device Deals

Start-Up Quarterly Statistics, Q3 2015

Start-ups raised $2.57 billion in Q3. Biopharma companies penned 23 alliances; 11 acquisitions were signed, none in the diagnostics industry.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
    • Pharmacogenetics-Pharmacogenomics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
    • Saliva-based Testing
  • Laboratory Testing Services
  • Research, Analytical Equipment & Supplies
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Helix Opco LLC
  • Senior Management
  • Robin Thurston, CEO
    James Lu, MD, PhD, Co-founder & SVP, Applied Genomics
    Justin Kao, Co-founder & SVP, BD
    Scott Burke, Co-founder & CTO
    Deena Bahri, Chief Marekting Officer
    Philippe Lyko, VP, Finance
    David Yu, VP, Product
    Jim Chou, VP, Engineering
    Will Lee, PhD, VP, Bioinformatics
    David Becker, PhD, VP, Lab Ops
    Marc Laurent, VP, Ops
    Gloria Lee, PhD, Director, Reg & QA
  • Contact Info
  • Helix Opco LLC
    Phone: (844) 211-2070
    San Carlos, CA
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register